LncRNA BACE1-AS levels have been found to be increased along with amyloid β levels across different regions in postmortem brains from Alzheimer’s disease patients, and BACE1-AS protects BACE1 mRNA from degradation10. Here, BACE1 is linked to early-onset autosomal dominant Alzheimer disease.